Literature DB >> 3332287

Oculotoxicities of systemically administered drugs.

P B Koneru1, E J Lien, R T Koda.   

Abstract

There have been many drugs reported to cause oculotoxic responses after their systemic administration. The severity of these toxicities range from minor ocular inconvenience to permanent loss of vision. This paper reviews the current literature and attempts to suggest some probable factors involved in the development of oculotoxicities by systemic drugs. Various drug entry and exit pathways in the eye are presented and the role of some intraocular structures in the toxicity development is examined. The issues of melanin binding, genetic heterogeneity, photosensitivity and environmental pollution are discussed.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3332287     DOI: 10.1089/jop.1986.2.385

Source DB:  PubMed          Journal:  J Ocul Pharmacol        ISSN: 8756-3320


  5 in total

1.  Presumed entecavir-induced ocular toxicity.

Authors:  M K M Muqit; P E Stanga; F J Vilar; N Patton
Journal:  Eye (Lond)       Date:  2011-10-21       Impact factor: 3.775

2.  Comparison between albino and pigmented rabbit ERGs.

Authors:  Gabriela Lourençon Ioshimoto; Amanda Alves Camargo; André Maurício Passos Liber; Balázs Vince Nagy; Francisco Max Damico; Dora Fix Ventura
Journal:  Doc Ophthalmol       Date:  2018-03-23       Impact factor: 2.379

3.  An improved method for the isolation and culture of retinal pigment epithelial cells from adult rats.

Authors:  Analena Langenfeld; Sylvie Julien; Ulrich Schraermeyer
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2015-04-26       Impact factor: 3.117

Review 4.  Drug-induced uveitis: A review.

Authors:  Manisha Agarwal; Parthopratim Dutta Majumder; Kalpana Babu; Vinaya Kumar Konana; Mallika Goyal; Sara Touhami; Dinu Stanescu-Segall; Bahram Bodaghi
Journal:  Indian J Ophthalmol       Date:  2020-09       Impact factor: 1.848

5.  Ocular Side Effects of Systemic Drugs Used in Dermatology.

Authors:  Bhanu Prakash; H Mohan Kumar; Saranya Palaniswami; Borra Harish Lakshman
Journal:  Indian J Dermatol       Date:  2019 Nov-Dec       Impact factor: 1.494

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.